Trials / Withdrawn
WithdrawnNCT03613792
Remifentanil Plus Ketamine for Dynamic Flexible Bronchoscopy
Remifentanil Plus Ketamine Versus Midazolam Plus Fentanyl for Dynamic Flexible Bronchoscopy: Randomized Double-blind Clinical Trial
- Status
- Withdrawn
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Beth Israel Deaconess Medical Center · Academic / Other
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
This randomized controlled pilot clinical trial will enroll patients undergoing dynamic flexible bronchoscopy will be randomized to receive one of the two anesthetic combinations described above. The study will determine if there is a difference when considering patient and physician and satisfaction when performing DFB. Also, safety and efficacy of the two pharmacological combinations (fentanyl + midazolam and remifentanil + ketamine) used will be evaluated.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Remifentanil | Opioid analgesic |
| DRUG | Fentanyl | Opioid analgesic |
| DRUG | Midazolam | Benzodiazepine |
| DRUG | Ketamine | Analgesic |
Timeline
- Start date
- 2023-09-01
- Primary completion
- 2023-12-01
- Completion
- 2023-12-01
- First posted
- 2018-08-03
- Last updated
- 2023-07-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03613792. Inclusion in this directory is not an endorsement.